Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Topics Community

Article

A Novel Prognostic Model of Early-Stage Lung Adenocarcinoma Integrating Methylation and Immune Biomarkers

21 Jan 2021

Abstract excerpt

Lung adenocarcinoma (LUAD) is caused by multiple biological factors. Therefore, it will be more meaningful to study the prognosis from the perspective of omics integration. Given the significance of epigenetic modification and immunity in tumorigenesis and development, we tried to combine aberrant methylation and tumor infiltration CD8 T cell-related genes to build a prognostic model, to explore the key...

Topics

Join the communities discussing this publication.

Cancer-related molecular mechanisms research
Ferroptosis and cancer prognosis
RNA modifications and cancer

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 33552145
DOI: 10.3389/fgene.2020.634634

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 31 Aug 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

0

discussions

0

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

A Novel Prognostic Model of Early-Stage Lung Adenocarcinoma Integrating Methylation and Immune BiomarkersPMID 33552145Read ↗

A Novel Prognostic Signature Revealed the Interaction of Immune Cells in Tumor Microenvironment Based on Single-Cell RNA Sequencing for Lung AdenocarcinomaSemantic proximity Read ↗

A methylation‐related lncRNA‐based prediction model in lung adenocarcinomasSemantic proximity Read ↗

Development of a Prognostic Model Based on Differentially Expressed Immune Genes of Lung AdenocarcinomaSemantic proximity Read ↗

Identification of 4 immune cells and a 5-lncRNA risk signature with prognosis for early-stage lung adenocarcinomaSemantic proximity Read ↗

Analysis of Clinical Implications and Immune Landscape in Prognostic Model based on Immune Cell Signatures for Lung Adenocarcinoma PatientsSemantic proximity Read ↗

Multi-omics Data Analyses Construct TME and Identify the Immune-Related Prognosis Signatures in Human LUADSemantic proximity Read ↗

Identification of prognostic molecular subtypes and model based on CD8+ T cells for lung adenocarcinomaSemantic proximity Read ↗

Identification of hub-methylated differentially expressed genes in lung adenocarcinoma and immunotherapy resistanceSemantic proximity Read ↗

Construction of a m6A RNA Methylation Regulator-related Signature for Prognosis and Immune Response in Lung AdenocarcinomaSemantic proximity Read ↗

Characteristic of Classification and Prognostic Scoring Based on M6a RNA Methylation Modification in Lung Adenocarcinoma and Tumor Microenvironment AssociationSemantic proximity Read ↗

Identification of novel gene signature for lung adenocarcinoma by machine learning to predict immunotherapy and prognosisSemantic proximity Read ↗

CD8+ T Cell-Associated Gene Signature Correlates With Prognosis Risk and Immunotherapy Response in Patients With Lung AdenocarcinomaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.